Molecular and translational biology of the blood-based VeriStrat® proteomic test used in cancer immunotherapy treatment guidance.

Autor: Koc MA; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, United States., Wiles TA; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, United States., Weinhold DC; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, United States., Rightmyer S; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, United States., Weaver AL; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, United States., McDowell CT; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, United States., Roder J; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, United States., Asmellash S; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, United States., Pestano GA; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, United States., Roder H; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, United States., Georgantas Iii RW; Biodesix Inc., 2970 Wilderness Place Suite 100, Boulder, CO 80301, United States.

Publikováno v: Journal of mass spectrometry and advances in the clinical lab [J Mass Spectrom Adv Clin Lab] 2023 Nov 20; Vol. 30, pp. 51-60. Date of Electronic Publication: 2023 Nov 20 (Print Publication: 2023).